Delayed Onset Malignant Hyperthermia after Sevoflurane

  • Turhan K
  • Baytaş V
  • Batislam Y
  • et al.
N/ACitations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Malignant hyperthermia is a hypermetabolic response to inhalation agents (such as halothane, sevoflurane, and desflurane), succinylcholine, vigorous exercise, and heat. Reactions develop more frequently in males than females (2 : 1). The classical signs of malignant hyperthermia are hyperthermia, tachycardia, tachypnea, increased carbon dioxide production, increased oxygen consumption, acidosis, muscle rigidity and rhabdomyolysis. In this case report, we present a case of delayed onset malignant hyperthermia-like reaction after the second exposure to sevoflurane.

Cite

CITATION STYLE

APA

Turhan, K. S. C., Baytaş, V., Batislam, Y., & Özatamer, O. (2013). Delayed Onset Malignant Hyperthermia after Sevoflurane. Case Reports in Anesthesiology, 2013, 1–3. https://doi.org/10.1155/2013/712710

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free